Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/18/25 16:18 | 8/15/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Hussain Iqbal J | X0 | O | GC | 13 | S.dm | -3,278 | 17.84 | 0 | -184 | 131 | D | |||||||||||||||
11/18/25 16:17 | 2/3/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Bush Tia L | X0 | O | Chief Te | 6 | S.dm | -4,709 | 23.17 | 0 | -203 | 148 | D | |||||||||||||||
10/27/25 19:56 | 7/29/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Accardi Mario Alberto | X0 | O | P,Orexin | 5 | S.d | -852 | 18.32 | 0 | -46 | 216 | D | |||||||||||||||
7/25/25 18:24 | 7/25/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Weinhoff Gregory M | X0 | O | Chief Bu | 14 | S.dm | -3,155 | 15.14 | 0 | -208 | 223 | D | |||||||||||||||
7/21/25 19:39 | 7/21/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Saha Saurabh | X0 | DO | CEO | 17 | S.dm | -15,142 | 15.77 | 0 | -960 | 862 | D | |||||||||||||||
3/19/25 16:47 | 3/17/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Chao David M | X0 | O | Chief Ad | 1 | S.d | -120 | 17.17 | 0 | -7 | 225 | D | |||||||||||||||
2/10/25 17:33 | 2/7/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Anderson Karen M. | X0 | O | Chief Pe | 3 | S.dm | -982 | 18.21 | 0 | -54 | 72 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |